Candel Therapeutics
Price & Volume
Stats
See moreOpen | $5.39 |
Previous Close | $5.15 |
Day Range | $5.20-$5.49 |
52W Range | $4.25-$9.13 |
Market Cap | $284.3M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$23M |
Diluted EPS | -$0.56 |
News
See moreYahoo Finance • 8 days ago
Candel Therapeutics Prices $100 Mln Shares Offering At $5.45/shr To Advance Aglatimagene;Stock Down
Yahoo Finance • 8 days ago
Candel Therapeutics launches $100M public stock offering; shares down
Yahoo Finance • 3 months ago
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
Yahoo Finance • 3 months ago
Candel pausing development of CAN-2409 in prostate cancer type
About
CEO | Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. |
CFO | Mr. Charles Schoch |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |
